Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vir Biotechnology, Inc. (VIR) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vir Biotechnology, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1706431.
Total stock buying since 2019: $139,119,686.
Total stock sales since 2019: $224,497,963.
Total stock option exercises since 2019: $2,762,529.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 278,729 | $1,877,226 | 0 | $0 |
| 2024 | 0 | $0 | 118,817 | $1,197,796 | 80,000 | $105,600 |
| 2023 | 5,000 | $119,209 | 3,764,298 | $100,334,859 | 5,000 | $7,650 |
| 2022 | 0 | $0 | 1,949,749 | $53,012,105 | 112,593 | $518,372 |
| 2021 | 11 | $477 | 870,079 | $42,560,564 | 330,315 | $1,024,809 |
| 2020 | 0 | $0 | 654,710 | $25,515,413 | 613,952 | $1,106,098 |
| 2019 | 6,950,000 | $139,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-02-17 | Rice Steven J. (Chief Administrative Officer) | Sale | 1,942 | 31.93 | 62,010 |
| 2022-02-17 | Pang Phillip (Chief Medical Officer) | Sale | 3,009 | 31.93 | 96,080 |
| 2022-02-17 | Virgin Herbert (EVP, Research & CSO) | Sale | 2,293 | 31.93 | 73,217 |
| 2022-02-17 | Horn Howard (CFO) | Sale | 2,393 | 31.93 | 76,410 |
| 2022-02-17 | Scangos George A (President and CEO) | Sale | 10,024 | 31.93 | 320,076 |
| 2022-02-16 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 31.54 | 157,700 |
| 2022-02-16 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 1.53 | 7,650 |
| 2022-02-08 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 33.94 | 46,667 |
| 2022-02-08 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2022-02-02 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 34.52 | 172,620 |
| 2022-02-02 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 1.53 | 7,650 |
| 2022-01-25 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 32.46 | 44,632 |
| 2022-01-25 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2022-01-19 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 35.05 | 175,265 |
| 2022-01-19 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 1.53 | 7,650 |
| 2022-01-18 | Sato Vicki L (Director) | Sale | 15,173 | 37.39 | 567,379 |
| 2022-01-11 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 35.10 | 48,262 |
| 2022-01-11 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2022-01-05 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 37.46 | 187,300 |
| 2022-01-05 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 1.53 | 7,650 |
| 2021-12-28 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 39.95 | 54,931 |
| 2021-12-28 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-12-20 | Softbank Vision Fund (aiv M1) L.p. (10% Owner) | Sale | 400,022 | 52.73 | 21,093,160 |
| 2021-12-20 | Sato Vicki L (Director) | Sale | 15,174 | 55.10 | 836,148 |
| 2021-12-15 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 50.88 | 254,390 |
| 2021-12-15 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 1.53 | 7,650 |
| 2021-12-15 | Virgin Herbert (EVP, Research & CSO) | Sale | 2,750 | 50.00 | 137,500 |
| 2021-12-15 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 2,750 | 1.53 | 4,207 |
| 2021-12-14 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 45.88 | 63,085 |
| 2021-12-14 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-12-01 | Pang Phillip (Chief Medical Officer) | Sale | 7,500 | 43.59 | 326,910 |
| 2021-11-30 | Napolitano Janet (Director) | Sale | 1,435 | 46.25 | 66,368 |
| 2021-11-30 | Napolitano Janet (Director) | Option Ex | 1,435 | 41.64 | 59,753 |
| 2021-11-30 | Rice Steven J. (Chief Administrative Officer) | Sale | 10,000 | 50.00 | 500,000 |
| 2021-11-30 | Rice Steven J. (Chief Administrative Officer) | Option Ex | 10,000 | 12.76 | 127,600 |
| 2021-11-30 | Virgin Herbert (EVP, Research & CSO) | Sale | 15,125 | 47.80 | 722,975 |
| 2021-11-30 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 15,125 | 1.53 | 23,141 |
| 2021-11-29 | Hanly Ann M. (Chief Technology Officer) | Buy | 11 | 43.39 | 477 |
| 2021-11-26 | Sato Vicki L (Director) | Sale | 15,174 | 36.80 | 558,403 |
| 2021-11-17 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 36.28 | 181,385 |
| 2021-11-17 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 5.17 | 25,875 |
| 2021-11-16 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 32.67 | 44,921 |
| 2021-11-16 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-11-03 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 36.47 | 182,330 |
| 2021-11-03 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 5.17 | 25,875 |
| 2021-11-02 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 36.94 | 50,792 |
| 2021-11-02 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-10-20 | Pang Phillip (Chief Medical Officer) | Sale | 4,000 | 39.65 | 158,596 |
| 2021-10-19 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 38.87 | 53,446 |
| 2021-10-19 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-10-19 | Sato Vicki L (Director) | Sale | 15,174 | 39.51 | 599,585 |
| 2021-10-06 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 34.56 | 172,780 |
| 2021-10-05 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 33.75 | 46,406 |
| 2021-10-05 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-09-27 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | .85 | 4,275 |
| 2021-09-22 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 8,000 | 1.53 | 12,240 |
| 2021-09-21 | Virgin Herbert (EVP, Research & CSO) | Sale | 4,125 | 50.00 | 206,250 |
| 2021-09-21 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 4,125 | 1.53 | 6,311 |
| 2021-09-17 | Sato Vicki L (Director) | Sale | 15,174 | 52.69 | 799,442 |
| 2021-09-15 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 49.97 | 249,850 |
| 2021-09-07 | Virgin Herbert (EVP, Research & CSO) | Sale | 4,125 | 49.50 | 204,187 |
| 2021-09-07 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 4,125 | 1.53 | 6,311 |
| 2021-09-01 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 49.52 | 247,575 |
| 2021-09-01 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 1.53 | 7,650 |
| 2021-08-30 | Napolitano Janet (Director) | Sale | 1,435 | 51.15 | 73,400 |
| 2021-08-30 | Napolitano Janet (Director) | Option Ex | 1,435 | 41.64 | 59,753 |
| 2021-08-25 | Virgin Herbert (EVP, Research & CSO) | Sale | 2,750 | 50.00 | 137,500 |
| 2021-08-25 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 2,750 | 1.53 | 4,207 |
| 2021-08-24 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 48.00 | 66,000 |
| 2021-08-24 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-08-23 | Rice Steven J. (Chief Administrative Officer) | Sale | 10,000 | 50.00 | 500,000 |
| 2021-08-23 | Rice Steven J. (Chief Administrative Officer) | Option Ex | 10,000 | 12.76 | 127,600 |
| 2021-08-23 | Virgin Herbert (EVP, Research & CSO) | Sale | 13,750 | 50.00 | 687,500 |
| 2021-08-23 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 13,750 | 1.53 | 21,037 |
| 2021-08-19 | Sato Vicki L (Director) | Sale | 15,174 | 44.94 | 681,919 |
| 2021-08-18 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 42.23 | 211,160 |
| 2021-08-18 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 1.53 | 7,650 |
| 2021-08-10 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 41.00 | 56,375 |
| 2021-08-10 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-08-04 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 34.92 | 174,605 |
| 2021-08-04 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 5.17 | 25,875 |
| 2021-07-29 | More Robert J (Director) | Sale | 11,670 | 37.11 | 433,038 |
| 2021-07-27 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 36.72 | 50,490 |
| 2021-07-27 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-07-21 | Pang Phillip (Chief Medical Officer) | Sale | 4,630 | 37.44 | 173,347 |
| 2021-07-21 | Pang Phillip (Chief Medical Officer) | Option Ex | 4,630 | 1.57 | 7,292 |
| 2021-07-19 | Sato Vicki L (Director) | Sale | 15,174 | 37.29 | 565,853 |
| 2021-07-15 | More Robert J (Director) | Sale | 11,670 | 35.56 | 415,008 |
| 2021-07-13 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 36.72 | 50,490 |
| 2021-07-13 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-07-07 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 40.54 | 202,680 |
| 2021-07-07 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 5.17 | 25,875 |
| 2021-07-01 | More Robert J (Director) | Sale | 11,670 | 45.25 | 528,067 |
| 2021-06-25 | Rice Steven J. (Chief Administrative Officer) | Sale | 3 | 50.00 | 150 |
| 2021-06-25 | Rice Steven J. (Chief Administrative Officer) | Option Ex | 3 | 12.76 | 38 |
| 2021-06-21 | Sato Vicki L (Director) | Sale | 15,174 | 46.38 | 703,709 |
| 2021-06-17 | More Robert J (Director) | Sale | 11,670 | 43.95 | 512,838 |
| 2021-06-16 | Pang Phillip (Chief Medical Officer) | Sale | 5,000 | 43.67 | 218,344 |
| 2021-06-16 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 5.17 | 25,875 |
| 2021-06-15 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 45.29 | 62,273 |
| 2021-06-15 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-06-02 | Pang Phillip (Chief Medical Officer) | Sale | 10,000 | 41.83 | 418,250 |
| 2021-06-02 | Pang Phillip (Chief Medical Officer) | Option Ex | 10,000 | .85 | 8,550 |
| 2021-06-01 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 42.51 | 58,451 |
| 2021-06-01 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-05-20 | More Robert J (Director) | Sale | 11,670 | 44.17 | 515,452 |
| 2021-05-19 | Ramasastry Saira (Director) | Sale | 10,000 | 43.73 | 437,280 |
| 2021-05-19 | Ramasastry Saira (Director) | Option Ex | 10,000 | 12.76 | 127,600 |
| 2021-05-19 | Sato Vicki L (Director) | Sale | 15,174 | 44.16 | 670,129 |
| 2021-05-04 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,375 | 46.03 | 63,291 |
| 2021-05-04 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,375 | 1.53 | 2,103 |
| 2021-04-27 | Virgin Herbert (EVP, Research & CSO) | Sale | 7,900 | 49.50 | 391,073 |
| 2021-04-27 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 7,900 | 1.53 | 12,087 |
| 2021-04-19 | Virgin Herbert (EVP, Research & CSO) | Sale | 2,340 | 48.00 | 112,320 |
| 2021-04-19 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 2,340 | 1.53 | 3,580 |
| 2021-04-16 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,500 | 1.53 | 5,355 |
| 2021-04-13 | Virgin Herbert (EVP, Research & CSO) | Sale | 5,560 | 43.57 | 242,243 |
| 2021-04-13 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 5,560 | 1.53 | 8,506 |
| 2021-04-09 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 14,000 | 1.53 | 21,420 |
| 2021-04-01 | Parrish Jay (Chief Business Officer) | Sale | 6,944 | 51.41 | 356,956 |
| 2021-04-01 | Parrish Jay (Chief Business Officer) | Option Ex | 6,944 | 1.53 | 10,624 |
| 2021-03-23 | Virgin Herbert (EVP, Research & CSO) | Sale | 7,900 | 53.60 | 423,408 |
| 2021-03-23 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 7,900 | 1.53 | 12,087 |
| 2021-03-10 | Virgin Herbert (EVP, Research & CSO) | Sale | 2,340 | 48.00 | 112,320 |
| 2021-03-10 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 2,340 | 1.53 | 3,580 |
| 2021-03-09 | Virgin Herbert (EVP, Research & CSO) | Sale | 5,560 | 44.80 | 249,087 |
| 2021-03-09 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 5,560 | 1.53 | 8,506 |
| 2021-03-01 | Parrish Jay (Chief Business Officer) | Sale | 6,944 | 63.44 | 440,534 |
| 2021-03-01 | Parrish Jay (Chief Business Officer) | Option Ex | 6,944 | 1.53 | 10,624 |
| 2021-02-23 | Virgin Herbert (EVP, Research & CSO) | Sale | 7,900 | 63.74 | 503,577 |
| 2021-02-23 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 18,900 | 1.53 | 28,917 |
| 2021-02-16 | Pang Phillip (Chief Medical Officer) | Option Ex | 10,000 | .85 | 8,550 |
| 2021-02-12 | Pang Phillip (Chief Medical Officer) | Option Ex | 10,000 | .85 | 8,550 |
| 2021-02-09 | Virgin Herbert (EVP, Research & CSO) | Sale | 7,900 | 71.16 | 562,164 |
| 2021-02-09 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 7,900 | 1.53 | 12,087 |
| 2021-02-01 | Parrish Jay (Chief Business Officer) | Sale | 6,944 | 69.91 | 485,427 |
| 2021-02-01 | Parrish Jay (Chief Business Officer) | Option Ex | 6,944 | 1.53 | 10,624 |
| 2021-01-26 | Virgin Herbert (EVP, Research & CSO) | Sale | 31,300 | 48.17 | 1,507,814 |
| 2021-01-26 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 31,300 | 1.53 | 47,889 |
| 2021-01-15 | Virgin Herbert (EVP, Research & CSO) | Sale | 10,530 | 38.00 | 400,140 |
| 2021-01-15 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 10,530 | 1.53 | 16,110 |
| 2021-01-12 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 29.36 | 111,695 |
| 2021-01-12 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2021-01-04 | Parrish Jay (Chief Business Officer) | Sale | 6,945 | 26.32 | 182,792 |
| 2021-01-04 | Parrish Jay (Chief Business Officer) | Option Ex | 6,945 | 1.49 | 10,313 |
| 2020-12-24 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 9,500 | 1.53 | 14,535 |
| 2020-12-22 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 31.19 | 118,681 |
| 2020-12-22 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2020-12-08 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 31.27 | 118,967 |
| 2020-12-08 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2020-12-01 | Parrish Jay (Chief Business Officer) | Sale | 6,945 | 31.53 | 218,968 |
| 2020-12-01 | Parrish Jay (Chief Business Officer) | Option Ex | 6,945 | 1.53 | 10,625 |
| 2020-11-27 | Pang Phillip (Chief Medical Officer) | Option Ex | 7,500 | .85 | 6,412 |
| 2020-11-27 | Virgin Herbert (EVP, Research & CSO) | Sale | 2,930 | 30.00 | 87,900 |
| 2020-11-27 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 2,930 | 1.53 | 4,482 |
| 2020-11-24 | Virgin Herbert (EVP, Research & CSO) | Sale | 2,340 | 27.29 | 63,849 |
| 2020-11-24 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 2,340 | 1.53 | 3,580 |
| 2020-11-12 | Pang Phillip (Chief Medical Officer) | Option Ex | 20,000 | .85 | 17,100 |
| 2020-11-10 | Virgin Herbert (EVP, Research & CSO) | Sale | 2,340 | 26.26 | 61,448 |
| 2020-11-10 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 2,340 | 1.53 | 3,580 |
| 2020-11-04 | Pang Phillip (Chief Medical Officer) | Option Ex | 5,000 | 1.53 | 7,650 |
| 2020-11-02 | Parrish Jay (Chief Business Officer) | Sale | 6,944 | 31.27 | 217,152 |
| 2020-11-02 | Parrish Jay (Chief Business Officer) | Option Ex | 6,944 | 1.53 | 10,624 |
| 2020-10-27 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 35.04 | 133,334 |
| 2020-10-27 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2020-10-21 | Pang Phillip (Chief Medical Officer) | Sale | 17,500 | 33.47 | 601,035 |
| 2020-10-21 | Pang Phillip (Chief Medical Officer) | Option Ex | 12,500 | 2.76 | 34,500 |
| 2020-10-13 | Virgin Herbert (EVP, Research & CSO) | Sale | 5,560 | 43.03 | 239,235 |
| 2020-10-13 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 5,560 | 1.53 | 8,506 |
| 2020-10-07 | Pang Phillip (Chief Medical Officer) | Sale | 12,500 | 41.74 | 521,762 |
| 2020-10-07 | Pang Phillip (Chief Medical Officer) | Option Ex | 12,500 | 1.55 | 19,412 |
| 2020-10-01 | Parrish Jay (Chief Business Officer) | Sale | 6,945 | 34.75 | 241,338 |
| 2020-10-01 | Parrish Jay (Chief Business Officer) | Option Ex | 6,945 | 1.53 | 10,625 |
| 2020-09-29 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,510 | 38.00 | 133,380 |
| 2020-09-29 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,510 | 1.53 | 5,370 |
| 2020-09-24 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,700 | 1.53 | 5,661 |
| 2020-09-22 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 31.70 | 120,637 |
| 2020-09-22 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2020-09-16 | Pang Phillip (Chief Medical Officer) | Sale | 12,500 | 31.90 | 398,737 |
| 2020-09-16 | Pang Phillip (Chief Medical Officer) | Option Ex | 12,500 | 2.76 | 34,500 |
| 2020-09-08 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 29.99 | 114,108 |
| 2020-09-08 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2020-09-02 | Pang Phillip (Chief Medical Officer) | Sale | 12,500 | 32.90 | 411,187 |
| 2020-09-02 | Pang Phillip (Chief Medical Officer) | Option Ex | 12,500 | 1.57 | 19,687 |
| 2020-09-01 | Parrish Jay (Chief Business Officer) | Sale | 6,943 | 39.15 | 271,797 |
| 2020-09-01 | Parrish Jay (Chief Business Officer) | Option Ex | 6,943 | 1.57 | 10,935 |
| 2020-08-25 | Virgin Herbert (EVP, Research & CSO) | Sale | 5,560 | 42.92 | 238,635 |
| 2020-08-25 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 25,560 | 1.53 | 39,106 |
| 2020-08-19 | Pang Phillip (Chief Medical Officer) | Sale | 12,500 | 50.95 | 636,887 |
| 2020-08-19 | Pang Phillip (Chief Medical Officer) | Option Ex | 26,500 | 2.54 | 67,177 |
| 2020-08-11 | Virgin Herbert (EVP, Research & CSO) | Sale | 7,900 | 51.08 | 403,563 |
| 2020-08-11 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 7,900 | 1.53 | 12,087 |
| 2020-08-05 | Pang Phillip (Chief Medical Officer) | Sale | 25,000 | 50.90 | 1,272,474 |
| 2020-08-05 | Pang Phillip (Chief Medical Officer) | Option Ex | 25,000 | 1.57 | 39,374 |
| 2020-08-03 | Parrish Jay (Chief Business Officer) | Sale | 11,110 | 47.65 | 529,402 |
| 2020-08-03 | Parrish Jay (Chief Business Officer) | Option Ex | 11,110 | 1.53 | 16,998 |
| 2020-07-28 | Virgin Herbert (EVP, Research & CSO) | Sale | 15,800 | 47.99 | 758,178 |
| 2020-07-28 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 15,800 | 1.53 | 24,174 |
| 2020-07-15 | Pang Phillip (Chief Medical Officer) | Sale | 12,500 | 49.53 | 619,137 |
| 2020-07-15 | Pang Phillip (Chief Medical Officer) | Option Ex | 12,500 | 3.38 | 42,187 |
| 2020-07-14 | Virgin Herbert (EVP, Research & CSO) | Sale | 7,900 | 48.84 | 385,875 |
| 2020-07-14 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 7,900 | 1.53 | 12,087 |
| 2020-07-13 | Horn Howard (CFO) | Sale | 30,000 | 50.06 | 1,501,740 |
| 2020-07-02 | Horn Howard (CFO) | Sale | 10,000 | 40.00 | 400,000 |
| 2020-07-01 | Pang Phillip (Chief Medical Officer) | Sale | 12,500 | 37.78 | 472,225 |
| 2020-07-01 | Pang Phillip (Chief Medical Officer) | Option Ex | 12,500 | 3.38 | 42,187 |
| 2020-07-01 | Parrish Jay (Chief Business Officer) | Sale | 75,000 | 37.95 | 2,846,325 |
| 2020-07-01 | Parrish Jay (Chief Business Officer) | Option Ex | 75,000 | 1.53 | 114,750 |
| 2020-07-01 | Horn Howard (CFO) | Sale | 10,000 | 38.61 | 386,120 |
| 2020-06-25 | Horn Howard (CFO) | Sale | 30,000 | 50.00 | 1,500,000 |
| 2020-06-24 | Virgin Herbert (EVP, Research & CSO) | Sale | 9,360 | 48.00 | 449,280 |
| 2020-06-24 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 9,360 | 1.53 | 14,320 |
| 2020-06-23 | Virgin Herbert (EVP, Research & CSO) | Sale | 5,560 | 38.99 | 216,778 |
| 2020-06-23 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 5,560 | 1.53 | 8,506 |
| 2020-06-19 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,510 | 38.00 | 133,383 |
| 2020-06-19 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,510 | 1.53 | 5,370 |
| 2020-06-19 | Horn Howard (CFO) | Sale | 10,000 | 40.00 | 400,000 |
| 2020-06-17 | Pang Phillip (Chief Medical Officer) | Sale | 12,500 | 37.27 | 465,825 |
| 2020-06-17 | Pang Phillip (Chief Medical Officer) | Option Ex | 12,500 | 5.17 | 64,687 |
| 2020-06-09 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 36.28 | 138,030 |
| 2020-06-09 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2020-06-03 | Pang Phillip (Chief Medical Officer) | Sale | 12,500 | 35.07 | 438,425 |
| 2020-06-03 | Pang Phillip (Chief Medical Officer) | Option Ex | 12,500 | 5.17 | 64,687 |
| 2020-06-01 | Parrish Jay (Chief Business Officer) | Sale | 75,000 | 35.22 | 2,641,425 |
| 2020-06-01 | Parrish Jay (Chief Business Officer) | Option Ex | 75,000 | 1.49 | 111,375 |
| 2020-06-01 | Horn Howard (CFO) | Sale | 10,000 | 34.96 | 349,570 |
| 2020-05-26 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 34.08 | 129,674 |
| 2020-05-26 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2020-05-18 | Virgin Herbert (EVP, Research & CSO) | Sale | 1,755 | 38.00 | 66,690 |
| 2020-05-18 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 1,755 | 1.53 | 2,685 |
| 2020-05-14 | Virgin Herbert (EVP, Research & CSO) | Sale | 3,805 | 30.07 | 114,420 |
| 2020-05-14 | Virgin Herbert (EVP, Research & CSO) | Option Ex | 3,805 | 1.53 | 5,821 |
| 2020-05-14 | Parrish Jay (Chief Business Officer) | Sale | 75,000 | 30.05 | 2,253,900 |
| 2020-05-14 | Parrish Jay (Chief Business Officer) | Option Ex | 75,000 | 1.49 | 111,375 |
| 2020-05-01 | More Robert J (Director) | Sale | 18,458 | 28.25 | 521,401 |
| 2020-04-17 | Pang Phillip (Chief Medical Officer) | Option Ex | 8,000 | .85 | 6,840 |
| 2019-10-16 | Platinum Falcon B 2018 Rsc Ltd | Buy | 1,000,000 | 20.00 | 20,000,000 |
| 2019-10-16 | Softbank Vision Fund (aiv M1) L.p. (10% Owner) | Buy | 950,000 | 20.00 | 19,000,000 |
| 2019-10-16 | Arch Venture Partners Ix, L.p. (10% Owner) | Buy | 1,000,000 | 20.00 | 20,000,000 |
| 2019-10-16 | Alaska Permanent Fund Corp | Buy | 1,500,000 | 20.00 | 30,000,000 |
| 2019-10-16 | Burow Kristina (Director) | Buy | 1,000,000 | 20.00 | 20,000,000 |
| 2019-10-16 | V-sciences Investments Pte Ltd (10% Owner) | Buy | 500,000 | 20.00 | 10,000,000 |
| 2019-10-16 | Nelsen Robert (Director) | Buy | 1,000,000 | 20.00 | 20,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of VIR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vir Biotechnology, Inc. (symbol VIR, CIK number 1706431) see the Securities and Exchange Commission (SEC) website.